FindTrial
Sign In

Pergolide

DRUG7 trials

Sponsors

National Institute on Drug Abuse (NIDA), Medical University of South Carolina, Children's Hospital Medical Center, Cincinnati, Bronx VA Medical Center, Bausch Health Americas, Inc.

Conditions

Cocaine-Related DisordersOther Personality DisordersParkinson DiseaseSchizophreniaSchizotypal Personality DisorderSubstance-Related DisordersTourette Syndrome

Phase 2

IV Cocaine Abuse: A Laboratory Model - 4
CompletedNCT00000215
National Institute on Drug Abuse (NIDA)Cocaine-Related Disorders
End: 2001-12-31Updated: 2017-01-12
Pergolide Treatment for Substance Abusers - 4
CompletedNCT00000269
National Institute on Drug Abuse (NIDA)Cocaine-Related Disorders, Substance-Related Disorders
Start: 1995-10-31End: 2001-12-31Updated: 2017-01-12

Phase 3

Dose Response Trial of Pergolide for Cocaine Dependence - 1
CompletedNCT00000248
Medical University of South CarolinaCocaine-Related Disorders
Start: 1996-02-29Updated: 2018-05-16

Unknown Phase

Randomized Study of Pergolide in Children With Tourette Syndrome
CompletedNCT00004433
Children's Hospital Medical Center, CincinnatiTourette Syndrome
Start: 1994-12-31End: 2002-09-30Target: 74Updated: 2015-03-25
Pergolide for Cognitive Symptoms in Schizotypal Personality Disorder
NCT00252044
Bronx VA Medical CenterOther Personality Disorders, Schizotypal Personality Disorder
Start: 2000-10-31Updated: 2005-11-21
Compassionate Use Study of Pergolide in Patients With Parkinson's Disease
NCT00624741
Bausch Health Americas, Inc.Parkinson Disease
Updated: 2012-06-22
Adjuvant Therapy With Pergolide in Treating Cognitive Deficits in Schizophrenia
CompletedNCT01066403
Heidelberg UniversitySchizophrenia
Start: 2003-10-31End: 2008-03-31Updated: 2010-02-10